Fifth Circuit Affirms Ruling Favoring Healthcare Providers

A federal appeals court has delivered another important chapter in the long-running battle over the No Surprises Act, and this round clearly favored healthcare providers. In Texas Medical Association v. U.S. Department of Health and Human Services, the U.S. Court of Appeals for the Fifth Circuit affirmed a lower court ruling that struck down portions of federal regulations governing payment disputes between out-of-network providers and health plans.

The August 2, 2024 decision did not weaken the No Surprises Act’s core protections for patients. Consumers are still generally shielded from surprise balance bills in covered situations. Instead, the fight centered on a less visible but enormously important question: When providers and insurers disagree over payment, how much influence should the insurer-calculated qualifying payment amount, or QPA, have over the independent dispute resolution process?

The Fifth Circuit’s answer was essentially: Congress listed several factors, so federal agencies cannot quietly turn one factor into the star quarterback while making the others sit on the bench.

Decision facts and holdings grounded in the Fifth Circuit opinion and official federal implementation materials.

What the Fifth Circuit Healthcare Ruling Was About

The dispute arose from implementation of the federal No Surprises Act, which Congress enacted as part of the Consolidated Appropriations Act, 2021. The law took effect in 2022 and was designed to stop patients from receiving massive, unexpected bills after unknowingly obtaining care from an out-of-network provider.

Think of the classic emergency-room scenario. A patient goes to an in-network hospital while experiencing chest pain. The patient does not pause at the door and ask every physician, anesthesiologist, radiologist, or helicopter crew member to produce an insurance-network membership card. That would be a particularly strange way to spend an emergency.

The No Surprises Act generally prevents covered out-of-network providers from billing patients for the difference between their charge and the amount paid by an insurer beyond applicable in-network cost sharing. The law instead moves many payment fights away from the patient’s kitchen table and into negotiations between health plans and healthcare providers.

When those parties cannot agree, the federal independent dispute resolution, or IDR, process may be available. The result is a form of final-offer arbitration sometimes compared with baseball salary arbitration.

How the IDR process generally works

A payer first makes an initial payment or denies payment for an eligible out-of-network claim. The provider and payer can then enter a 30-business-day open negotiation period. If negotiations fail and the statutory requirements are satisfied, a party may initiate federal IDR.

Each side submits a proposed payment amount. A certified IDR entity reviews the dispute and chooses one of the two offers rather than simply splitting the difference. This format is supposed to encourage reasonable offers. In theory, demanding the financial equivalent of a private island is risky because the arbitrator must choose one side’s number.

Federal IDR workflow and communication requirements synthesized from CMS, DOL, and Federal Register materials.

The QPA Became the Center of the Legal Fight

The qualifying payment amount is generally tied to the median contracted rate for the same or similar item or service in the applicable insurance market and geographic area, subject to the methodology established under the No Surprises Act.

The QPA matters in several parts of the law. It can affect patient cost sharing, and it is one of the factors Congress instructed IDR arbitrators to consider when resolving payment disputes.

But Congress did not stop with the QPA.

The statute also directs arbitrators to consider specified additional circumstances when relevant information is submitted. Those circumstances include factors such as the provider’s training and experience, patient acuity or case complexity, market share, a facility’s scope of services, and certain evidence regarding good-faith efforts to enter network agreements. Similar provisions, with differences appropriate to the industry, apply to air ambulance disputes.

That distinction became the heart of the litigation.

The government’s earlier QPA presumption had already been struck down

Federal regulators initially adopted an IDR framework containing what they described as a rebuttable presumption that the QPA was the appropriate payment amount. Healthcare providers challenged that approach in earlier litigation.

A federal district court in the Eastern District of Texas concluded that the presumption conflicted with the statute because it gave disproportionate influence to the QPA. The challenged provisions were vacated.

The Departments of Health and Human Services, Labor, and Treasury later issued a revised final rule in 2022. The new regulations eliminated the express rebuttable presumption language.

Problem solved? Not exactly. Healthcare law rarely ends with everyone shaking hands and leaving early for lunch.

Why Healthcare Providers Challenged the Revised Rules

The Texas Medical Association, Tyler Regional Hospital, physician Adam Corley, and air ambulance providers challenged provisions of the revised regulatory framework. Their central argument was that the new rules still placed the QPA in a privileged position, even without officially calling it a presumption.

The disputed requirements effectively did three things.

First, the rule directed IDR entities to consider the QPA and then consider information involving additional statutory circumstances.

Second, the regulations instructed arbitrators not to give weight to certain information characterized as not credible, unrelated to an offer, or already accounted for in the QPA or other information.

Third, when an IDR entity relied on non-QPA information in selecting an offer, the written decision had to explain why that information was not already reflected in the QPA.

Providers argued that these procedures still tilted the process toward insurer-calculated QPAs. The federal government responded that the rules were reasonable procedural and evidentiary guardrails designed to improve consistent decision-making.

The district court sided with the provider plaintiffs and vacated the challenged provisions. The federal Departments appealed.

What the Fifth Circuit Decided

The Fifth Circuit affirmed the district court’s judgment. The appellate court concluded that the challenged regulatory provisions exceeded the authority Congress delegated to the Departments.

1. Arbitrators could not be required to consider the QPA first

The court focused closely on the statutory text. Congress required arbitrators to consider the QPA and information involving the listed additional circumstances. But the statute did not tell arbitrators that one factor must be considered before another.

According to the majority, being listed first does not automatically mean a factor must be analyzed first.

The court concluded that requiring arbitrators to begin with the QPA placed a regulatory thumb on the scale in favor of the insurer-determined figure. In other words, regulators had created a hierarchy that Congress itself did not establish.

This point is especially important for healthcare providers. The decision does not say the QPA is irrelevant. Far from it. The QPA remains a mandatory consideration. The court’s objection was to agency regulations giving it preferential treatment over other congressionally identified factors.

The court’s analysis of QPA sequencing and statutory factors is reflected in the published opinion.

2. Mandatory statutory factors must receive genuine consideration

The Fifth Circuit also rejected regulatory provisions that could prevent an arbitrator from giving weight to some information associated with the statutory additional circumstances.

The court stressed Congress’s use of mandatory language. When a statute directs a decision-maker to consider identified factors, an agency cannot effectively authorize the decision-maker to ignore one of those factors entirely because the agency believes the information overlaps with another consideration.

This does not mean providers can submit a 700-page binder filled with motivational quotes, cafeteria menus, and the weather forecast and demand serious consideration of every page. An IDR submission still needs a focused connection to the payment dispute.

The broader legal point is that regulators cannot erase congressionally mandated considerations through additional limitations that materially change the statutory decision-making structure.

3. The court rejected the special explanation burden for non-QPA information

The appeals court was also troubled by the asymmetric explanation requirement.

Under the challenged rule, an IDR entity relying on non-QPA information had to explain why that information was not already reflected in the QPA. There was no equivalent special explanation requirement triggered simply because the arbitrator selected an offer associated with the QPA.

The Fifth Circuit reasoned that making an arbitrator work harder only when giving weight to non-QPA circumstances could influence outcomes. The additional burden made departures from a QPA-centered approach less attractive and therefore risked biasing the IDR process.

For providers, this part of the opinion may be particularly significant. Administrative requirements can shape outcomes even when no regulation explicitly says, “Insurers win this tie.” The design of a process matters.

Loper Bright Had a Supporting Role in the Decision

The Fifth Circuit’s opinion also arrived shortly after the U.S. Supreme Court decided Loper Bright Enterprises v. Raimondo, a landmark administrative-law case rejecting the Chevron framework for judicial deference to agency interpretations of ambiguous statutes.

The Fifth Circuit cited Loper Bright while discussing the judicial responsibility to identify the boundaries of authority Congress delegated to an agency.

That does not mean every healthcare regulation is suddenly standing on a trapdoor. Agencies still possess rulemaking authority granted by Congress. However, courts are expected to independently determine statutory meaning and police the limits of delegated power.

In the No Surprises Act dispute, the Fifth Circuit found that the Departments crossed those limits by adding requirements that distorted the decision-making framework Congress created.

Administrative-law analysis is grounded in the Fifth Circuit’s express discussion of delegated authority and Loper Bright.

The Court Also Upheld Broad Vacatur of the Challenged Provisions

The federal government argued against vacating the provisions or, alternatively, sought relief limited to the plaintiffs in the case.

The Fifth Circuit rejected those arguments.

Under binding circuit precedent concerning the Administrative Procedure Act, the court concluded that vacatur was an available remedy. It also found broad vacatur appropriate because a plaintiff-specific approach could undermine the uniformity of the federal IDR system.

The result was not merely a personalized regulatory exemption for the Texas Medical Association and named providers. The specific unlawful provisions of the final rule remained vacated.

Why the Fifth Circuit Ruling Favors Healthcare Providers

The most obvious benefit for providers is greater room to present case-specific circumstances during No Surprises Act arbitration.

A QPA is a standardized payment metric. A complex medical encounter, however, may contain facts that do not fit neatly into a median contracted rate. A severely unstable emergency patient may require unusually intensive resources. A provider may possess specialized training. A facility may maintain costly capabilities necessary to treat high-acuity cases. An air ambulance mission may involve operational circumstances that distinguish it from a routine transport.

The ruling reinforces the statutory importance of those additional factors.

For physician groups, hospitals, facilities, and air ambulance providers, the decision therefore reduces the risk that the QPA will function as a de facto benchmark from which every other argument must fight uphill.

The Texas Medical Association publicly welcomed the ruling, maintaining that the federal rules had improperly favored the QPA and disadvantaged physicians. Medical specialty organizations likewise viewed the decision as confirmation that the QPA should not receive special regulatory preference.

Provider reaction and the healthcare community’s interpretation are supported by TMA and specialty-organization materials.

But This Is Not a Blank Check for Providers

The court’s ruling is favorable to healthcare providers, but it does not guarantee that a provider’s offer will prevail in every IDR case. Nor did the Fifth Circuit declare the QPA invalid.

Certified IDR entities must still consider the QPA. Providers still have to submit an offer and develop a persuasive payment argument. The baseball-style structure still creates substantial risk for parties that choose unrealistic numbers.

Existing federal IDR data also show why the policy debate remains heated. Research based on CMS data has found that providers prevailed in a large majority of decided disputes during early periods of the program. One peer-reviewed analysis of 2023 IDR outcomes reported provider victories in approximately 86% of cases and found average selected amounts substantially above the QPA.

Brookings researchers similarly observed that provider offers frequently prevailed in early federal arbitration data and raised questions about the potential effect of IDR awards on healthcare spending and insurance premiums.

Insurers and health policy analysts have therefore warned that an arbitration process producing payments well above typical in-network rates could create upward cost pressure. Provider organizations counter that high success rates may demonstrate that insurer offers and QPAs do not always accurately reflect the value of disputed services.

Welcome to healthcare payment policy, where every spreadsheet eventually becomes a battlefield.

IDR outcome data and policy concerns synthesized from peer-reviewed research, Brookings analysis, GAO reporting, and federal rulemaking records.

What Does the Decision Mean for Patients?

For patients, the most important message is what the ruling did not do.

The Fifth Circuit did not eliminate the No Surprises Act’s major consumer billing protections. Eligible patients remain generally protected against surprise balance billing for covered emergency services and certain services received from out-of-network providers at in-network facilities.

The litigation primarily concerned how providers and payers resolve the remaining payment amount between themselves.

There may still be indirect consequences for consumers. Payment levels can influence insurance premiums, network contracting, provider participation, and the economics of emergency or specialty services. Researchers and policymakers continue to debate whether the federal IDR process is producing sustainable market outcomes.

Still, a patient receiving a covered emergency service should not suddenly become the referee in a heavyweight reimbursement fight because of the Fifth Circuit’s ruling. Keeping patients out of that fight was a fundamental purpose of the No Surprises Act.

Consumer protection background synthesized from KFF, GAO, CMS, and DOL.

Experiences and Practical Lessons: What the Provider-Side Reality Can Look Like

The easiest way to understand the significance of Texas Medical Association v. HHS is to move away from abstract regulatory language and imagine how actual payment disputes develop. The following examples are hypothetical, but they reflect the types of operational issues highlighted by the No Surprises Act’s statutory factors and federal IDR framework.

Experience 1: The emergency case that looks routine only on a claim form

Imagine an out-of-network emergency physician treats a patient whose billing code initially appears comparable to dozens of other cases in the geographic region. The payer’s QPA provides a useful benchmark based on contracted rates.

But the actual encounter involves a rapidly deteriorating patient, multiple simultaneous clinical problems, extended physician management, and coordination with several specialists.

Before the Fifth Circuit ruling, a provider might worry that the QPA would operate as the gravitational center of the arbitration. Every additional fact could be treated as an attempt to escape the “normal” number.

After the ruling, the better practical lesson is not simply “ask for more money.” It is “document why this case is different.”

A strong provider submission might clearly connect patient acuity and case complexity to the payment offer. The argument should be specific, organized, and tied to the statutory circumstances. A five-page explanation showing what occurred may be much more effective than 100 pages of generic statements about the importance of emergency medicine.

Experience 2: Specialized capability has to be demonstrated, not admired

Consider a facility that maintains advanced trauma capabilities around the clock. Staffing, specialized equipment, and readiness create substantial fixed expenses, even at 3:17 a.m. when most of the city is sleeping and somebody’s cat is knocking a glass off a kitchen counter.

If a disputed service is treated solely as another billing code, the facility may believe a standardized payment metric misses meaningful facts regarding its scope of services.

The Fifth Circuit decision gives statutory additional circumstances genuine room in the analytical process. Yet that opportunity creates a documentation challenge.

Providers need evidence that explains the relationship between the relevant facility characteristic and the disputed service. A vague statement that “we are highly specialized” is marketing copy. Information describing the resources, capabilities, staffing, or complexity associated with the actual case is an argument.

That difference matters enormously in IDR.

Experience 3: Air ambulance disputes demonstrate why one number may not tell the whole story

Air ambulance services were also involved in the Fifth Circuit litigation. Their payment disputes illustrate the difficulty of creating a single standardized benchmark for services delivered under highly variable conditions.

Imagine two transports covering similar distances. On a spreadsheet, they may appear nearly identical. Yet one operation could involve a different aircraft type, highly specialized medical personnel, unusual patient complexity, or difficult logistical circumstances.

The provider-side lesson from the ruling is that relevant statutory factors cannot automatically be pushed aside merely because an insurer-calculated QPA already exists.

At the same time, providers should resist treating the court decision as permission to submit every operational detail they possess. The goal is to identify facts that genuinely distinguish the service and explain why the submitted payment offer better reflects its value.

The biggest practical experience: IDR is becoming a documentation discipline

Across physician, facility, and air ambulance disputes, one lesson stands out: effective IDR strategy increasingly depends on structured evidence.

Providers need internal processes that identify eligible claims, preserve negotiation deadlines, collect relevant case information, and connect that information to the statutory framework. Revenue-cycle employees, contracting teams, clinicians, and legal advisors may all hold different pieces of the puzzle.

A clinician understands acuity. A contracting executive may know the history of network negotiations. A revenue-cycle specialist understands the claim and payment trail. An attorney may recognize which details actually relate to the No Surprises Act’s IDR criteria.

When those teams operate in separate silos, a provider may have strong facts but a weak submission. When they work together, the payment narrative becomes easier for an IDR entity to evaluate.

That may be the most useful experience-based takeaway from the Fifth Circuit ruling. Winning the legal argument that additional factors deserve consideration is only step one. Providers still have to present those factors persuasively, accurately, and in a way that makes sense to an independent decision-maker.

What Healthcare Organizations Should Watch Next

The Fifth Circuit decision is part of a broader series of lawsuits involving implementation of the No Surprises Act. Separate litigation has addressed QPA calculation methodology, administrative fees, payment deadlines, and other parts of the federal IDR framework.

Federal agencies have repeatedly updated rules, guidance, FAQs, and IDR procedures as courts have reviewed implementation decisions and the dispute system has processed a far greater volume of claims than initially anticipated.

Healthcare organizations should therefore avoid treating one court decision as the final page of the No Surprises Act story. Compliance teams need to follow current federal guidance, judicial developments, and operational updates affecting federal IDR.

Providers should also review their evidence-collection procedures. The Fifth Circuit ruling makes case-specific statutory factors more meaningful, but only when organizations can identify and communicate those facts.

Payers, meanwhile, have an incentive to reassess how they defend initial payments and IDR offers in an environment where the QPA cannot be given regulatory priority over other mandatory considerations.

Continuing implementation complexity is documented in CMS rule and guidance indexes, GAO findings, CRS analysis, and later federal IDR operational rulemaking.

Conclusion: A Provider Victory With Broader Regulatory Implications

The Fifth Circuit’s ruling in Texas Medical Association v. HHS was a meaningful victory for healthcare providers challenging the federal implementation of the No Surprises Act.

By affirming the lower court’s judgment, the appeals court rejected regulatory provisions that required arbitrators to start with the QPA, limited consideration of some additional information, and imposed a special explanation requirement when non-QPA factors influenced a payment decision.

The ruling does not erase the QPA, guarantee larger reimbursements, or weaken the central surprise-billing protections enjoyed by patients. Instead, it reinforces a straightforward administrative-law principle with major financial consequences: Agencies must implement the system Congress enacted, not redesign its hierarchy through procedural details.

For providers, that means training, complexity, acuity, facility characteristics, and other applicable statutory circumstances can play a genuine role in IDR decisions without an agency-created preference for the QPA.

For insurers and policymakers, the decision adds another challenge to an arbitration system already dealing with enormous dispute volumes and intense debate about healthcare costs.

And for everyone following No Surprises Act litigation, one thing is certain: despite the law’s name, the legal surprises are apparently not finished yet.